Harbin Gloria Pharmaceuticals (002437) — Free Cash Flow Generation Index
Harbin Gloria Pharmaceuticals (002437) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of CN¥178.63 Million represents 1% of operating cash flow (CN¥182.89 Million). See 002437 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Harbin Gloria Pharmaceuticals Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Harbin Gloria Pharmaceuticals across 19 annual periods. Explore how well can Harbin Gloria Pharmaceuticals service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year Free Cash Flow Generation Index for Harbin Gloria Pharmaceuticals. For the full company profile including market capitalisation, see 002437 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | CN¥249.54 Million | CN¥273.36 Million | CN¥23.81 Million | ▲ +7.8% |
| 2024 | 0.85x | CN¥348.04 Million | CN¥410.94 Million | CN¥62.90 Million | ▼ -5.0% |
| 2023 | 0.89x | CN¥244.55 Million | CN¥274.18 Million | CN¥29.62 Million | ▲ +2.1% |
| 2022 | 0.87x | CN¥228.60 Million | CN¥261.62 Million | CN¥33.01 Million | ▼ 0.0% |
| 2021 | 0.87x | CN¥239.67 Million | CN¥274.18 Million | CN¥34.51 Million | ▲ +136.1% |
| 2020 | -2.42x | CN¥-30.90 Million | CN¥12.76 Million | CN¥43.66 Million | ▼ -362.9% |
| 2019 | 0.92x | CN¥561.94 Million | CN¥610.37 Million | CN¥48.43 Million | ▲ +1.1% |
| 2018 | 0.91x | CN¥1.06 Billion | CN¥1.16 Billion | CN¥104.34 Million | ▲ +29.8% |
| 2017 | 0.70x | CN¥457.16 Million | CN¥651.80 Million | CN¥194.63 Million | ▼ -14.7% |
| 2016 | 0.82x | CN¥855.14 Million | CN¥1.04 Billion | CN¥185.34 Million | ▲ +37.7% |
| 2015 | 0.60x | CN¥418.95 Million | CN¥702.05 Million | CN¥283.10 Million | ▼ -26.6% |
| 2014 | 0.81x | CN¥548.14 Million | CN¥674.04 Million | CN¥125.89 Million | ▲ +27.2% |
| 2013 | 0.64x | CN¥289.67 Million | CN¥453.02 Million | CN¥163.35 Million | ▲ +114.0% |
| 2012 | 0.30x | CN¥61.52 Million | CN¥205.89 Million | CN¥144.37 Million | ▲ +200.3% |
| 2011 | -0.30x | CN¥-38.30 Million | CN¥128.61 Million | CN¥166.90 Million | ▲ +73.9% |
| 2010 | -1.14x | CN¥-128.29 Million | CN¥112.59 Million | CN¥240.88 Million | ▼ -278.0% |
| 2009 | 0.64x | CN¥109.34 Million | CN¥170.82 Million | CN¥61.47 Million | ▲ +87.5% |
| 2008 | 0.34x | CN¥19.73 Million | CN¥57.81 Million | CN¥38.08 Million | ▼ -54.4% |
| 2007 | 0.75x | CN¥39.09 Million | CN¥52.26 Million | CN¥13.17 Million | — |